Draper Asset Management LLC Has $769,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Draper Asset Management LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 39.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,565 shares of the medical equipment provider’s stock after purchasing an additional 440 shares during the period. Intuitive Surgical makes up approximately 0.6% of Draper Asset Management LLC’s investment portfolio, making the stock its 14th largest holding. Draper Asset Management LLC’s holdings in Intuitive Surgical were worth $769,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Creekmur Asset Management LLC boosted its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares in the last quarter. Ridgewood Investments LLC acquired a new position in Intuitive Surgical in the second quarter valued at about $26,000. Godsey & Gibb Inc. grew its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $30,000. Finally, LGT Financial Advisors LLC lifted its holdings in shares of Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $547.87 on Friday. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The company has a market capitalization of $195.14 billion, a price-to-earnings ratio of 88.08, a PEG ratio of 5.41 and a beta of 1.39. The company has a 50-day simple moving average of $504.73 and a 200 day simple moving average of $463.54.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. This trade represents a 15.83 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,655,048.26. This represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,935 shares of company stock worth $26,305,169 in the last ninety days. 0.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on ISRG. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a report on Friday, October 18th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their target price for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $524.61.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.